(Q43676843)

25 November 2017

title

Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing (English)

1 reference

25 November 2017

Barber DS

1

1 reference

25 November 2017

Hunt JR

2

1 reference

25 November 2017

Ehrich MF

3

1 reference

25 November 2017

Lehning EJ

4

1 reference

25 November 2017

LoPachin RM

5

1 reference

25 November 2017

language of work or name

1 reference

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

22

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

341-353

1 reference

Neurotoxicity of glycidamide, an acrylamide metabolite, following intraperitoneal injections in rats.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Determination of acrylamide and glycidamide in rat plasma by reversed-phase high performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

CYP2E1-dependent benzene toxicity: the role of extrahepatic benzene metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Acrylamide and glycidamide impair neurite outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bidirectional transport of organelles observed by video microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

The metabolism and pharmacokinetics of acrylamide: implications for mechanisms of toxicity and human risk estimation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioral, neurochemical and morphological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Effect of acrylamide on brain and hepatic mixed-function oxidases and glutathione-S-transferase in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Binding of acrylamide with glutathione-S-transferases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

The distribution and metabolism of acrylamide and its neurotoxic analogues in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Acrylamide as an inducer of metabolic activation system (S9) in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Toxic neurofilamentous axonopathies and fast axonal transport. V. Reduced bidirectional vesicle transport in cultured neurons by acrylamide and glycidamide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Biochemical studies on acrylamide, a neurotoxic agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Pharmacokinetics of acrylamide after oral administration in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Biochemical and morphologic characterization of acrylamide peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Mechanism of calcium entry during axon injury and degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Acrylamide disrupts elemental composition and water content of rat tibial nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Pharmacokinetics of acrylamide in Fisher-344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Comparison of subchronic neurotoxicity of 2-hydroxyethyl acrylate and acrylamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Comparison of central and peripheral nervous system lesions caused by high-dose short-term and low-dose subchronic acrylamide treatment in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

The pathogenesis of dying-back polyneuropathies. II. An ultrastructural study of experimental acrylamide intoxication in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Determination of acrylamide in rat serum and sciatic nerve by gas chromatography-electron-capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Selective Preparation of 2,3-Epoxypropanamide and Its Facile Conversion to 2,3-Dihydroxypropanamide with Acidic Resins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Characterization and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

Acrylamide neuropathy in rats. An electron microscopic study of degeneration and regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2801%2900024-9

7 January 2021

10.1016/S0161-813X(01)00024-9

Identifiers

DOI

1 reference

25 November 2017

1 reference